CTOs on the Move

Inflexxion Inc

www.inflexxion.com

 
Inflexxion Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newton Upper Falls, MA. To find more information about Inflexxion Inc, please visit www.inflexxion.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.inflexxion.com
  • 320 Needham St
    Newton Upper Falls, MA USA 02464-1592
  • Phone: 617.332.6028

Executives

Name Title Contact Details

Similar Companies

RamSoft

RamSoft, Inc. is a Rancho Cucamonga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Puritan's Pride

Puritan's Pride is a Bohemia, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orion Health

Orion Health develops fully integrated modern healthcare software, positioning us apart from our competitors and also setting a new standard in healthcare technology. Orion Health has extensive experience in the design and installation of complex systems within demanding healthcare environments. With an inherent ability to interconnect the wide variety of information systems found in health, Orion Health has risen to be considered a global leader in its industry. Today, Orion Health products and solutions are implemented in more than 30 countries, used by hundreds of thousands of clinicians, and help facilitate care for tens of millions of patients. We believe that our software, built on new generation technology, will give everyone healthier, happier and longer lives.

Retreat Nursing Home

Retreat Nursing Home is a Monticello, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics, Inc. is a clinical stage, private biopharmaceutical company with a diversified portfolio of four products and a deep early stage pipeline for the treatment of pain.  Relmada’s strategy focuses on two complementary pillars: the improvement of proven drug candidates with novel delivery methods and pharmaceutical compositions and the development of d-methadone as an innovative NMDA (N-Methyl-D-aspartate) inhibitor platform. The Company is currently developing several drug candidates including: LevoCap ER, its abuse resistant, once–a-day sustained release dosage form of the opioid analgesic levorphanol; d-methadone, the NDMA receptor antagonist for diabetic painful neuropathy (DPN); BuCap, its oral dosage form of the opioid analgesic buprenorphine; MepiGel, its FDA Orphan Drug designated topical formulation of the local anesthetic mepivacaine.